Tag: top
Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Mumbai: Dishonest FIR filed towards health co, Shilpa Shetty, Raj | Mumbai Information
Mumbai: A Pune businessman has filed a police complaint against the owner of SFL Fitness Pvt Ltd and four others including Bollywood actress Shilpa...